Romosozumab is associated with greater trabecular bone score improvement compared to denosumab in postmenopausal osteoporosis

[1] Krohn K(2019)Dual-energy X-ray Absorptiometry Monitoring with Trabecular Bone Score: 2019 ISCD Official Position J Clin Densitom 22 501-505

[2] Schwartz EN(2004)Bone mineral density thresholds for pharmacological intervention to prevent fractures Arch Intern Med 164 1108-1112

[3] Chung YS(2008)Correlations between grey-level variations in 2D projection images (TBS) and 3D microarchitecture: applications in the study of human trabecular bone microarchitecture Bone 42 775-787

[4] Lewiecki EM(2017)Use of trabecular bone score (TBS) as a complementary approach to dual-energy X-ray absorptiometry (DXA) for fracture risk assessment in clinical practice J Clin Densitom 20 334-345

[5] Siris ES(2017)Effects of sclerostin antibodies in animal models of osteoporosis Bone 96 63-75

[6] Chen YT(2021)Emerging insights into the comparative effectiveness of anabolic therapies for osteoporosis Nat Rev Endocrinol 17 31-46

[7] Abbott TA(2016)Romosozumab treatment in postmenopausal women with osteoporosis N Engl J Med 375 1532-1543

[8] Barrett-Connor E(2017)Romosozumab or alendronate for fracture prevention in women with osteoporosis N Engl J Med 377 1417-1427

[9] Miller PD(2019)Bone-forming and antiresorptive effects of romosozumab in postmenopausal women with osteoporosis: Bone histomorphometry and microcomputed tomography analysis after 2 and 12 months of treatment J Bone Miner Res 34 1597-1608

[10] Wehren LE(2020)Pharmacological management of osteoporosis in postmenopausal women: An endocrine society guideline update J Clin Endocrinol Metab 105 587-597

[1] Krohn K(2019)Dual-energy X-ray Absorptiometry Monitoring with Trabecular Bone Score: 2019 ISCD Official Position J Clin Densitom 22 501-505

[2] Schwartz EN(2004)Bone mineral density thresholds for pharmacological intervention to prevent fractures Arch Intern Med 164 1108-1112

[3] Chung YS(2008)Correlations between grey-level variations in 2D projection images (TBS) and 3D microarchitecture: applications in the study of human trabecular bone microarchitecture Bone 42 775-787

[4] Lewiecki EM(2017)Use of trabecular bone score (TBS) as a complementary approach to dual-energy X-ray absorptiometry (DXA) for fracture risk assessment in clinical practice J Clin Densitom 20 334-345

[5] Siris ES(2017)Effects of sclerostin antibodies in animal models of osteoporosis Bone 96 63-75

[6] Chen YT(2021)Emerging insights into the comparative effectiveness of anabolic therapies for osteoporosis Nat Rev Endocrinol 17 31-46

[7] Abbott TA(2016)Romosozumab treatment in postmenopausal women with osteoporosis N Engl J Med 375 1532-1543

[8] Barrett-Connor E(2017)Romosozumab or alendronate for fracture prevention in women with osteoporosis N Engl J Med 377 1417-1427

[9] Miller PD(2019)Bone-forming and antiresorptive effects of romosozumab in postmenopausal women with osteoporosis: Bone histomorphometry and microcomputed tomography analysis after 2 and 12 months of treatment J Bone Miner Res 34 1597-1608

[10] Wehren LE(2020)Pharmacological management of osteoporosis in postmenopausal women: An endocrine society guideline update J Clin Endocrinol Metab 105 587-597